UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

Comparison of robot‐assisted partial nephrectomy for complex (RENAL scores ≥10) and non‐complex renal tumors: A single‐center experience

International journal of urology, 2021-10, Vol.28 (10), p.1054-1059

2021

Volltextzugriff (PDF)

Efficacy of Combination Therapy With Radium-223 and Enzalutamide in Castration-resistant Prostate Cancer With Bone Metastases

Anticancer research, 2024-06, Vol.44 (6), p.2627

2024

Volltextzugriff (PDF)

MP28-07 THE ASSOCIATION OF SOLUBLE PD-L1 AND TREATMENT RESPONSE TO NIVOLUMAB IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA

The Journal of urology, 2023-04, Vol.209 (Supplement 4)

2023

Volltextzugriff (PDF)

Prognostic Value of Serum Soluble PD-L1 in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab

Anticancer research, 2023-02, Vol.43 (2), p.841

2023

Volltextzugriff (PDF)

The Efficacy of Presurgical Therapy With Avelumab and Axitinib for Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus

Clinical genitourinary cancer, 2023-10, Vol.21 (5), p.613.e1-613.e6

2023

Volltextzugriff (PDF)

MP18-11 PREDICTIVE EFFICACY OF SERUM SOLUBLE PD-L1 ON PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH NIVOLUMAB

The Journal of urology, 2020-04, Vol.203 (Supplement 4)

2020

Volltextzugriff (PDF)

Therapeutic outcome of combination therapy using immunecheckpoint inhibitors and tyrosine kinase inhibitors for metastatic non-clear-cell renal cell carcinoma

Canadian Urological Association journal, 2024-05, Vol.18 (5), p.E162

2024

Volltextzugriff (PDF)

Therapeutic outcome of combination therapy using immune-checkpoint inhibitors and tyrosine kinase inhibitors for metastatic non-clear-cell renal cell carcinoma

Canadian Urological Association journal, 2024-05, Vol.18 (5), p.E162-E166

2024

Volltextzugriff (PDF)

A pathological complete response and adrenal insufficiency in a patient with advanced renal pelvic cancer treated with pembrolizumab

International cancer conference journal, 2024-07

2024

Volltextzugriff (PDF)

The Efficacy of Presurgical Therapy With Avelumab and Axitinib for Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus

Clinical genitourinary cancer, 2023, Vol.21 (5), p.613.e1-613.e6

2023

Volltextzugriff (PDF)

Treatment-free remission after two-year consolidation therapy with nilotinib in patients with chronic myeloid leukemia: STAT2 trial in Japan

Haematologica (Roma), 2018-11, Vol.103 (11), p.1835

2018

Volltextzugriff (PDF)

Identification of Target Speech Utterances from Real Public Conversation

Digital Human Modeling and Applications in Health, Safety, Ergonomics and Risk Management. Human Communication, Organization and Work, p.52-63

Volltextzugriff (PDF)

Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients

PloS one, 2021-04, Vol.16 (4), p.e0249449-e0249449

2021

Volltextzugriff (PDF)

Antipruritic effect of the topical phosphodiesterase 4 inhibitor E6005 ameliorates skin lesions in a mouse atopic dermatitis model

The Journal of pharmacology and experimental therapeutics, 2013-07, Vol.346 (1), p.105

2013

Volltextzugriff (PDF)

Diverse Effects of Cyclosporine on Hepatitis C Virus Strain Replication

Journal of Virology, 2006-05, Vol.80 (9), p.4510-4520

2006

Volltextzugriff (PDF)

Effect of the phosphodiesterase 4 inhibitor E6005 on nerve growth factor elevation in irritated skin of NC/Nga mice

Journal of dermatological science, 2014-12, Vol.76 (3), p.263-264

2014

Volltextzugriff (PDF)

Two-Year Consolidation By Nilotinib Is Associated with Successful Treatment Free Remission in Chronic Myeloid Leukemia with MR4.5: Subgroup Analysis from STAT2 Trial in Japan

Blood, 2016-12, Vol.128 (22), p.1889-1889

2016

Volltextzugriff (PDF)

Development of an intervention system for linkage-to-care and follow-up for hepatitis B and C virus carriers

Hepatology international, 2022-02, Vol.16 (1), p.68-80

2022

Volltextzugriff (PDF)

Development of an intervention system for linkage-to-care and follow-up for hepatitis B and C virus carriers

Hepatology international, 2022-02, Vol.16 (1), p.68-80

2022

Volltextzugriff (PDF)

A putative antipruritic mechanism of the phosphodiesterase-4 inhibitor E6005 by attenuating capsaicin-induced depolarization of C-fibre nerves

Experimental dermatology, 2015-03, Vol.24 (3), p.215-216

2015

Volltextzugriff (PDF)

Protein quality control machinery supports primary ciliogenesis by eliminating GDP-bound Rab8-family GTPases

iScience, 2023-05, Vol.26 (5), p.106652-106652, Article 106652

2023

Volltextzugriff (PDF)

Switching to Nilotinib Are Associated with Deeper Molecular Responses in Chronic Myeloid Leukemia with Persistent Residual Disease on Long-Term Imatinib Therapy: STAT1 Trial in Japan

Blood, 2015-12, Vol.126 (23), p.4032-4032

2015

Volltextzugriff (PDF)

Esophageal Cancer Patients Have a High Incidence of Severe Periodontitis and Preoperative Dental Care Reduces the Likelihood of Severe Pneumonia after Esophagectomy

Digestive surgery, 2016-01, Vol.33 (6), p.495-502

2016

Volltextzugriff (PDF)

Development of Dose Management Software Using Visual Basic for Applications and Dose Evaluation in the Field of Nuclear Medicine

Japanese Journal of Radiological Technology, 2022, pp.2022-1298

2022

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Aktive Filter

ThemaPhysical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(36)

Publikationsform

Sprache

Englisch
(39)
Japanisch
(20)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Comparison of robot‐assisted partial nephrectomy for complex (RENAL scores ≥10) and non‐complex renal tumors: A single‐center experience

Efficacy of Combination Therapy With Radium-223 and Enzalutamide in Castration-resistant Prostate Cancer With Bone Metastases

MP28-07 THE ASSOCIATION OF SOLUBLE PD-L1 AND TREATMENT RESPONSE TO NIVOLUMAB IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA

Prognostic Value of Serum Soluble PD-L1 in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab

The Efficacy of Presurgical Therapy With Avelumab and Axitinib for Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus

MP18-11 PREDICTIVE EFFICACY OF SERUM SOLUBLE PD-L1 ON PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH NIVOLUMAB

Therapeutic outcome of combination therapy using immunecheckpoint inhibitors and tyrosine kinase inhibitors for metastatic non-clear-cell renal cell carcinoma

Therapeutic outcome of combination therapy using immune-checkpoint inhibitors and tyrosine kinase inhibitors for metastatic non-clear-cell renal cell carcinoma

A pathological complete response and adrenal insufficiency in a patient with advanced renal pelvic cancer treated with pembrolizumab

The Efficacy of Presurgical Therapy With Avelumab and Axitinib for Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus

Treatment-free remission after two-year consolidation therapy with nilotinib in patients with chronic myeloid leukemia: STAT2 trial in Japan

Identification of Target Speech Utterances from Real Public Conversation

Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients

Antipruritic effect of the topical phosphodiesterase 4 inhibitor E6005 ameliorates skin lesions in a mouse atopic dermatitis model

Diverse Effects of Cyclosporine on Hepatitis C Virus Strain Replication

Effect of the phosphodiesterase 4 inhibitor E6005 on nerve growth factor elevation in irritated skin of NC/Nga mice

Two-Year Consolidation By Nilotinib Is Associated with Successful Treatment Free Remission in Chronic Myeloid Leukemia with MR4.5: Subgroup Analysis from STAT2 Trial in Japan

Development of an intervention system for linkage-to-care and follow-up for hepatitis B and C virus carriers

Development of an intervention system for linkage-to-care and follow-up for hepatitis B and C virus carriers

A putative antipruritic mechanism of the phosphodiesterase-4 inhibitor E6005 by attenuating capsaicin-induced depolarization of C-fibre nerves

Protein quality control machinery supports primary ciliogenesis by eliminating GDP-bound Rab8-family GTPases

Switching to Nilotinib Are Associated with Deeper Molecular Responses in Chronic Myeloid Leukemia with Persistent Residual Disease on Long-Term Imatinib Therapy: STAT1 Trial in Japan

Esophageal Cancer Patients Have a High Incidence of Severe Periodontitis and Preoperative Dental Care Reduces the Likelihood of Severe Pneumonia after Esophagectomy

A multicenter clinical study evaluating the confirmed complete molecular response rate in imatinib-treated patients with chronic phase chronic myeloid leukemia by using the international scale of real-time quantitative polymerase chain reaction

Development of Dose Management Software Using Visual Basic for Applications and Dose Evaluation in the Field of Nuclear Medicine

Aktive Filter

Suchergebnisse filtern